• It is also advisable to perform the CEA (Carcinoembryonic Antigen) test. (mrlabtest.com)
  • Abstract]Objective To evaluate the value of combined detection of antigen 199 (CA199), carbohydrate antigen 125 (CA125), carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in the diagnosis of ovarian cancer, so as to provide reference for the diagnosis of ovarian cancer, and to intervene as early as possible and promote the prognosis of patients. (zgyyzn2004.com)
  • Carcinoembryonic antigen is used to detect relapse of colorectal cancer, and CA 19-9 may be helpful in establishing the nature of pancreatic masses. (aafp.org)
  • Materials and Method: Data for the tumor markers carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), cancer antigen 125 (CA 125), cancer antigen 15-3 (CA 15-3) and alpha-fetoprotein (AFP) that were ordered by all the clinics in our Hospital between 2010 and 2011 were screened. (erdogan.edu.tr)
  • This CEA Blood Test measures the protein in the blood called carcinoembryonic antigen (CEA). (walkinlab.com)
  • Her C-reactive protein concentration was 11 mg/L. Her CA-125 and carcinoembryonic antigen levels were within normal range. (biomedcentral.com)
  • One third of all ovarian tumors are serous, and two thirds of these serous tumors are benign. (medscape.com)
  • Of these tumors, 75% are benign and are found in women aged 30-50 years. (medscape.com)
  • RESULTS: The levels of suPAR(II-III), HE4, CA125 were all higher in EOC II than in EOC I, borderline and benign ovarian tumors. (lu.se)
  • B7-H4 was increased in EOC II compared with benign ovarian tumors. (lu.se)
  • The combination of suPAR(II-III), HE4, CA125 and age in premenopausal women discriminates EOC and borderline tumors from benign tumors to higher accuracy compared to the Risk of Ovarian Malignancy Algorithm (p=0.007). (lu.se)
  • CONCLUSION: The biomarker panel suPAR(II-III), HE4, CA125 and age in premenopausal women improved discrimination of malignant and benign ovarian tumors. (lu.se)
  • The plasma levels of B7-H4 were increased in patients with EOC II compared to those with benign ovarian tumors. (lu.se)
  • A moderate CA 125 increase may be due to malignant tumors and in some cases due to benign diseases. (mrlabtest.com)
  • Tumors of low malignant potential and benign epithelial cystadenomas were not included. (tau.ac.il)
  • The correlation between the clinical status and concordant fluctuations in the serum levels of CA 125 in all histological types was 87.8 and 93.5% when 10 cases of mucinous tumors were excluded. (tau.ac.il)
  • Methods Selected patients with ovarian cancer and benign ovarian tumors admitted to our hospital from August 2018 to October 2019, 80 cases each were selected as observation group 1 and observation group 2. (zgyyzn2004.com)
  • 3%-6% of benign ovarian and uterine tumors can also significantly increase cancer antigen 125. (sekbio.com)
  • Cancer antigen 125 can also identify pelvic tumors and masses, especially for postmenopausal women, to determine ovarian masses and cancer. (sekbio.com)
  • similarly, low-activity concentrations of 89 Zr-DFO-mAb-B43.13 accumulated in CA125-negative SKOV3 tumors. (snmjournals.org)
  • Giant cell tumors (GCTs) are benign or noncancerous. (medicinenet.com)
  • Giant cell tumors (GCTs) are benign (noncancerous) tumors that most commonly occur in the bones of the arms and legs. (medicinenet.com)
  • Although giant cell tumors are benign, they can cause problems if they press on nearby structures or grow and weaken the bone to the point of fracture . (medicinenet.com)
  • Unlike the invasive carcinomas, borderline ovarian tumors are characterized by cytoplasmic and nuclear atypia, (element of differential diagnosis with benign tumors), absence of stromal invasion, (element of differential diagnosis with malignant tumors), unusual degree of proliferation of the epithelial cells with cellular stratification including remarkable architectural atypia and the formation of papillary protuberances. (intechopen.com)
  • Fibroids, also known as leiomyomas, are benign smooth muscle tumors that occur in the uterus. (globalguideline.com)
  • Leiomyomas are benign tumors observed mainly in adult women. (biomedcentral.com)
  • In all postmenopausal women with a pelvic mass, the cancer antigen 125 (CA-125) level, though an imprecise indicator, should be ordered and pelvic ultrasonography performed. (medscape.com)
  • However, if the mass is solid or partially solid, you're past menopause or at high risk of ovarian cancer, your doctor may order a cancer antigen 125 (CA-125) blood test. (healthline.com)
  • A high level of CA-125 in your blood could be due to various health conditions, including ovarian cancer. (healthline.com)
  • PATIENTS AND METHODS: Preoperative plasma levels of B7-family protein homolog 4 (B7-H4), intact and cleaved soluble urokinase plasminogen activator receptor (suPAR), human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) were analyzed in 350 patients with adnexal lesions. (lu.se)
  • High concentrations of CA 125 antigen are associated with ovarian cancer and other malignant disease (pancreatic, lung, cervical, etc. (mrlabtest.com)
  • If the rate CA-125/CEA is high (over 25) there is a high probability to be a malignant ovarian cancer . (mrlabtest.com)
  • The CA-125 antigen level is very high and a severe increase is usually a sign of ovarian cancer . (mrlabtest.com)
  • If the high level is due to an ovarian cancer the concentration of CA 125 correlates with tumor size and staging. (mrlabtest.com)
  • The typical values of CA-125 in case of ovarian cancer are between 65 U/ml and 100 U/ml. (mrlabtest.com)
  • Cancer antigen 125 (CA 125) is the only tumor marker recommended for clinical use in the diagnosis and management of ovarian cancer . (medscape.com)
  • However, owing to the lack of sensitivity and specificity, elevations in single or sequential CA 125 levels alone are not recommended for ovarian cancer screening or in the initial diagnosis of ovarian cancer. (medscape.com)
  • The Gynecologic Cancer Intergroup (GCIG) defines a response to treatment as a reduction of 50% or more in pretreatment CA 125 levels maintained for at least 28 days. (medscape.com)
  • A study by Potenza et al indicated that in patients with epithelial ovarian cancer, combined analysis of CA 125 and human epididymis protein 4 (HE4) is an effective indicator of success in chemotherapy. (medscape.com)
  • A CA 125 test , where levels of the protein cancer antigen 125 are checked in blood work for early signs of ovarian cancer, took place the next day. (foundationforwomenscancer.org)
  • The hysterectomy found the original mass to be benign, but caught cancer next to it. (foundationforwomenscancer.org)
  • You may have a blood test for CA-125 A to measure cancer activity. (medlineplus.gov)
  • The combination of two tumour markers, CA125 and HE4, in the risk of ovarian malignancy assay (ROMA) has been shown to be successful in classifying patients into those who have a high or low risk of epithelial ovarian cancer. (nih.gov)
  • Cancer antigen (CA) 27.29 most frequently is used to follow response to therapy in patients with metastatic breast cancer. (aafp.org)
  • CA 125 is useful for evaluating pelvic masses in postmenopausal women, monitoring response to therapy in women with ovarian cancer, and detecting recurrence of this malignancy. (aafp.org)
  • Cancer antigen (CA) 27.29 is a monoclonal antibody to a glycoprotein (MUC1) that is present on the apical surface of normal epithelial cells. (aafp.org)
  • CA 27.29 is highly associated with breast cancer, although levels are elevated in several other malignancies ( Table 1 ) . (aafp.org)
  • Human epididymis protein 4 (HE4) is a tumor cell surface antigen in female ovarian cancer. (whdsbio.cn)
  • Although cancer antigen 125 (CA125) is widely used in the clinical diagnosis of ovarian cancer detection, studies have shown that HE4 is superior to CA125 in the early diagnosis of ovarian cancer, especially for patients with benign ovarian cancer, HE4 is currently ovarian cancer The most sensitive tumor marker for diagnosis. (whdsbio.cn)
  • The current biomarker for accurate determination of ovarian cancer prognosis, cancer antigen 125 (CA-125), leaves much to be desired. (ascopost.com)
  • As for a comparison between CA-125 and threonyl tRNA-synthetase, the levels of CA-125 in ovarian cancer patients were much lower than levels of threonyl tRNA-synthetase (0.145-12.0 pg/mL vs 266-896 pg/mL). (ascopost.com)
  • Of note, although overall expression of CA-125 in patients with advanced-stage ovarian cancer was a marker for increased mortality, overexpression of threonyl tRNA-synthetase was associated with increased survival in patients with advanced-stage ovarian cancer. (ascopost.com)
  • CA 125 is a protein found on the surface of many cancer cells (ovarian, pancreatic, breast, lung, colorectal, etc.) and normal cells. (biron.com)
  • High CA 125 levels are found in 80% of ovarian cancer cases and in varying percentages of other cancers. (biron.com)
  • For this reason, CA 125 testing is not recommended in asymptomatic individuals unless there is a pelvic mass on ultrasound or a family history of ovarian cancer (BRCA1 or BRCA2 gene mutation). (biron.com)
  • A decrease in CA 125 levels during the treatment of ovarian cancer is one indication (but not the only one) of a favourable response to treatment, whereas a renewed increase after treatment may be a sign of the disease's recurrence. (biron.com)
  • Aims: To investigate the incidence of ordering tests for tumor markers which are used in cancer diagnosis, follow-up treatment and detection of recurrence, the rate of elevation in benign diseases and which clinics order them frequently. (erdogan.edu.tr)
  • The identification of putative prognostic factors in canine mammary neoplasms (CMNs) has been focused on tissue-specific biomarkers, but the serum biomarkers, including cancer antigen 15-3 (CA 15-3), c-reactive protein (CRP), and lactate dehydrogenase (LDH) have been demonstrated to display clinical application in cases of CMNs. (scielo.br)
  • Darlix A, Lamy PJ, Lopez-Crapez E, Braccini AL, Firmin N, Romieu G, Thezenas S, Jacot W. Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients. (scielo.br)
  • Di Gioia D, Blankenburg I, Nagel D, Heinemann V, Stieber P. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3. (scielo.br)
  • What Does Cancer Antigen 125 Mean? (sekbio.com)
  • The serum cancer antigen 125 marker of patients with ovarian epithelial cancer is significantly increased, reaching several times the average value. (sekbio.com)
  • At the same time, cancer antigen 125 mainly exists in ovarian cancer tissue cells. (sekbio.com)
  • It is known that the cancer antigen 125 is significantly increased in decompensated liver cirrhosis, liver cancer, and other diseases, but the increase is usually less than 100,000 U/L. Mild elevations of cancer antigen 125 may also occur in acute and chronic pancreatitis, benign gastrointestinal illness, endometriosis, other diseases, or pregnancy. (sekbio.com)
  • Serum levels of cancer antigen 125 was increased in two patients with MACF. (iiarjournals.org)
  • The elevation of cancer antigen 125 (CA125) levels in the serum of asymptomatic patients precedes the radiologic detection of high-grade serous ovarian cancer by at least 2 mo and the final clinical diagnosis by 5 mo. (snmjournals.org)
  • PET imaging of CA125 expression by ovarian cancer cells may enhance the evaluation of the extent of disease and provide a roadmap to surgery as well as detect recurrence and metastases. (snmjournals.org)
  • High-grade serous ovarian cancer (HGSOC) comprises the major malignant histotype (70%) of epithelial ovarian cancers and bears a molecular signature in the overexpression of MUC16/cancer antigen 125 (CA125), a serum biomarker for ovarian cancer ( 3 ). (snmjournals.org)
  • A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. (pfeiffertheface.com)
  • CA 72.4 (GI Cancer) Test. (pfeiffertheface.com)
  • also known as: Cancer Antigen - GI. (pfeiffertheface.com)
  • These blood tests check for specific markers such as CA-125 and the prostate-specific antigen, which can determine diagnosis for ovarian cancer and prostate cancer respectively. (walkinlab.com)
  • The Prostate-Specific Antigen (PSA) Serum Test measures PSA levels in the blood to screen for prostate cancer or other benign prostate conditions. (walkinlab.com)
  • Cancer antigen 125 (CA-125) is a protein found in ovarian cancer cells. (walkinlab.com)
  • The Carbohydrate Antigen (CA) 19-9 Blood Test is used primarily to monitor response to pancreatic cancer therapy and to monitor recurrence, sometimes to help diagnose pancreatic cancer. (walkinlab.com)
  • The Cancer Antigen (CA) 15-3 Blood Test monitors invasive breast cancer treatment and detects possible recurrences. (walkinlab.com)
  • The Cancer Antigen 27.29 Blood Test monitors patients with metastatic breast cancer. (walkinlab.com)
  • The CA-125 blood test is not recommended as a large-scale screening for ovarian cancer. (cancerquest.org)
  • CA-125, an ovarian cancer antigen, was thought to be a possible screening tool. (globalguideline.com)
  • CA-125 is elevated in women with a known ovarian cancer, and is used to monitor progression or regression of the tumor. (globalguideline.com)
  • The use of cancer antigen 125 (CA-125) can be used in combination with radiologic testing to determine the risk of adnexal masses. (ovariancystatoz.com)
  • Evaluation usually includes ultrasonography, CT or MRI, and measurement of tumor markers (eg, cancer antigen 125). (msdmanuals.com)
  • Int J Cancer 125(4):982-987. (who.int)
  • Objectives To perform an external validation of the diagnostic performance of the three-step strategy proposed by the International Ovarian Tumor Analysis (IOTA) group for classifying adnexal masses as benign or malignant, when ultrasound is performed by non-expert sonographers in the first two steps. (unav.edu)
  • Here, we investigated the possibility of serum-derived small extracellular vesicle (sEV) microRNAs (miRNAs) as potential biomarkers for distinguishing between benign and malignant adnexal masses and predicting the prognosis of EOC patients. (bvsalud.org)
  • Right adnexal masses, by and large are benign processes. (ovariancystatoz.com)
  • The sEVmiR-EOC model showed better performance than carbohydrate antigen 125 (CA125) in discriminating patients with stage I EOC from benign patients. (bvsalud.org)
  • From June 1, 1984, to May 31, 1985, 98 cases of epithelial ovarian carcinomas were assessed and followed prospectively using a new murine monoclonal antibody OC 125 which detects the antigen CA 125. (tau.ac.il)
  • Our mission is to make diagnosis more accurate, providing a comprehensive range of high-quality antigens/antibodies (monoclonal antibody/recombinant protein), Covid-19 LFA uncut sheets, chemiluminescence immunoassay reagents, and custom services. (sekbio.com)
  • What is a high CA 125 (Carcinoma Antigen) in a blood test called? (mrlabtest.com)
  • What does a high CA 125 (Carcinoma Antigen) mean? (mrlabtest.com)
  • Which values are considered a high CA 125 (Carcinoma Antigen) in a blood test? (mrlabtest.com)
  • Moderately high CA 125 levels are also found in a large number of benign conditions including menstruation, pregnancy, endometriosis, cirrhosis of the liver, peritonitis and acute pancreatitis, etc. (biron.com)
  • Elevations in CA 125 levels are used as an adjunct to aid in differentiation of malignant from benign pelvic masses detected with clinical examination or imaging. (medscape.com)
  • CA 125 can be used to calculate a risk of malignancy index (RMI), which is used to form the basis of algorithms in the management of pelvic masses in the United Kingdom. (medscape.com)
  • Two hundred and sixteen (76.3%) women underwent surgery (154 benign and 62 malignant masses) and 67 (23.7%) were managed expectantly with serial ultrasound follow-up for at least 12 months. (unav.edu)
  • All expectantly managed masses were considered benign because no sonographic changes suggestive of malignancy were observed during follow-up. (unav.edu)
  • Ultrasound, especially subjective assessment by ultrasound, remains superior in discriminating malignant from benign ovarian masses. (nih.gov)
  • However, tumor recurrence may occur in the setting of normal CA 125 levels, and serum measurements do not replace imaging and physical examination of the patient. (medscape.com)
  • [ 4 ] Although increasing CA 125 levels correlate with tumor recurrence after primary treatment, management of biochemical relapses remain controversial. (medscape.com)
  • Persistent elevation of CA 125 after three cycles of chemotherapy is indicative of a poor prognosis. (mrlabtest.com)
  • Up to 80% of women with ovarian carcinoma of epithelial origin have elevated serum CA 125 levels, with the frequency of elevation correlating with the clinically detected stage. (medscape.com)
  • In recurrent HGSOC, the elevation in serum CA125 levels precedes radiologic detection by 3 mo and predates the clinical presentation of symptoms and diagnosis by a median lag time of 5 mo ( 3 ). (snmjournals.org)
  • In fact, an elevation of serum levels of Ca 72.4 should always be taken seriously. (pfeiffertheface.com)
  • If the CA-125 level is elevated or the ultrasonographic features of the mass suggest malignancy, the patient should be referred for evaluation by a gynecologic oncologist. (medscape.com)
  • Negativization of CA 125 and HE4 following the third cycle of chemotherapy correlated with long progression-free survival (the odds ratios [ORs] being 9.1 and 5.5, respectively), as did "biomarker serum levels lower than the mean value in the affected population at the time of diagnosis" (ORs = 3.7 and 3.4, respectively). (medscape.com)
  • A preoperative ultrasound was performed and preoperative CA125 and HE4 serum levels were measured. (nih.gov)
  • LETTER TO THE EDITOR : Is the Determination of CA-125 Serum Levels Useful for the Diagnosis of Pulmonary Tuberculosis? (openrespiratorymedicinejournal.com)
  • 1 ] found higher CA-125 serum levels in patients with pulmonary tuberculosis than in other lung infections and concluded that this tumor marker is useful for the diagnosis of tuberculosis. (openrespiratorymedicinejournal.com)
  • Female dogs with CMNs were found to exhibit highest serum levels of CA 15-3, CRP, and LDH. (scielo.br)
  • MADISON, N.J. and FREMONT, Calif. , Sept. 11 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration ( FDA ) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. (questdiagnostics.com)
  • The OVA1 Test provides a new option in the pre-operative evaluation to help physicians assess if a pelvic mass is benign or malignant in order to help determine whether to refer a woman to a gynecologic oncologist for surgery. (questdiagnostics.com)
  • Physicians often do not know if a woman's pelvic mass is malignant or benign until she undergoes surgery. (questdiagnostics.com)
  • Indeed, among epithelial ovarian cancers, the frequency of CA125 positivity is higher in serous histotypes than in mucinous or clear cell disease ( 4 ). (snmjournals.org)
  • [ 4 ] This is particularly useful in postmenopausal women, in whom confounding variables from benign and physiologic conditions are absent or infrequent. (medscape.com)
  • Theca lutein cysts are an uncommon type of follicular cysts that reflect a benign ovarian lesion of a physiological exaggeration of follicle stimulation often termed as hyperreactio lutealis. (wikipedia.org)
  • This case highlights the concentration on vigilance to the SK of GC and a closer observation for intra-abdominal nodules, even radiological suspicion of a benign lesion. (springeropen.com)
  • The radiological findings diagnosed the lesion as benign. (springeropen.com)
  • There was no significant difference in initial CA 125 levels between early stages I and II and late stages III and IV. (tau.ac.il)
  • As such, baseline levels in patients who undergo serial CA 125 monitoring should be redetermined if the methodology in the assay is changed. (medscape.com)
  • Declining CA 125 levels have been shown to correlate with treatment response, even when disease is not detectable with physical examination or imaging. (medscape.com)
  • However, CA 27.29 levels higher than 100 units per mL are rare in benign conditions. (aafp.org)
  • Therefore, it is not clear which test was actually used, but given the marked non-Gaussian distribution of CA-125, if parametric tests had been used to assess the differences in CA-125 levels, their results would not have been reliable. (openrespiratorymedicinejournal.com)
  • Finally, the decrease in CA-125 levels following therapy reported by the authors is not unexpected, as the pleural fluid and inflammation disappeared. (openrespiratorymedicinejournal.com)
  • CA 125 levels can vary depending on the testing technique used. (biron.com)
  • It has been determined that in which benign diseases were the tumor markers frequently ordered and which of these conditions had high levels of them. (erdogan.edu.tr)
  • The levels of CA 15-3, CRP and LDH were significantly higher in the serum of female dogs with CMNs compared to the healthy ones. (scielo.br)
  • However, elevated serum CA125 levels alone do not qualify as a criterion to initiate treatment in the absence of radiologic evidence of recurrent disease. (snmjournals.org)
  • Ten percent of HGSOCs are reported to be biochemically silent (i.e., have normal serum CA125 levels), and 50% of patients with normal serum CA125 levels at the completion of chemotherapy are found to have active small-volume disease during second-look surgery ( 5 , 6 ). (snmjournals.org)
  • Rising levels of CA 125 in the absence of clinical or radiographic findings indicate what is termed as a biochemical relapse, which precedes a clinically detected relapse by 2-6 months. (medscape.com)
  • Therefore, whenever serous effusion of any etiology is present, CA-125 is expected to be substantially elevated, losing its diagnostic value. (openrespiratorymedicinejournal.com)
  • The most important advantage of the CA 72‑4 marker over others is its particularly high diagnostic specificity for benign illnesses. (pfeiffertheface.com)
  • However, it can be elevated also in benign diseases. (mrlabtest.com)
  • For example, the serum CA-125 is elevated in 1% of normal healthy women, 3% of normal healthy women with benign ovarian diseases, 6% of patients with non-neoplastic conditions ( endometriosis , uterine fibrosis, acute salpingitis, hepatic diseases and inflammation of the peritoneum or pericardium). (mrlabtest.com)
  • It may be also high in some benign diseases. (mrlabtest.com)
  • Results: CA 19-9 was ordered for 1,858 patients 191 (10.3%) were malignant while 1667 (89.7%) were ordered in benign diseases. (erdogan.edu.tr)
  • CA 15-3 was ordered 1449 times, 174 (12%) for malignant and 1275 (88%) for benign diseases. (erdogan.edu.tr)
  • In our experience CA 125 was invaluable in the management and follow-up of patients with ovarian carcinoma especially for the early detection of recurrent disease and for the monitoring of patients on therapy. (tau.ac.il)
  • 1 - 14 CA 27.29 also can be found in patients with benign disorders of the breast, liver, and kidney, and in patients with ovarian cysts. (aafp.org)
  • The control group consisted of 12 patients who were identified as having benign pathologies. (ascopost.com)
  • Also, the alleged conclusion about the usefulness of CA-125 in tuberculosis patients with negative sputum smears did not derive from the study, because all but one of the patients had positive sputum smears, which represented a quicker and much more reliable procedure than CA-125 for the diagnosis of tuberculosis in this series. (openrespiratorymedicinejournal.com)
  • L'étude portait sur 20 patients atteints d'un carcinome gastrique, 20 patients souffrant d'une gastrite à H. pylori et 20 personnes en tant que groupe témoin. (who.int)
  • however, rabbit antibodies raised against the recombinant proteins encoded by the gene of mouse bullous pemphigoid antigen 2 (BP180) are capable of inducing blisters in newborn mice in a complement-dependent manner. (medscape.com)
  • A 2-year interim analysis from the International Ovarian Tumor Analysis Phase 5 (IOTA5) study showed that 80% of ovarian cysts considered benign on ultrasonography either disappeared or required no intervention. (medscape.com)
  • The radiological impressions included benign stromal tumor, benign epithelial tumor, and borderline epithelial tumor. (iiarjournals.org)
  • CA 125 correlates with disease progression or regression in 80% to 90% of cases. (mrlabtest.com)
  • In this setting, serial CA 125 testing has more clinical utility than a single determination. (medscape.com)
  • A decrease in the CA 125 concentration by a factor of 10 after the first cycle of chemotherapy is indicative of improvement. (mrlabtest.com)
  • What is the normal CA 125 (Carcinoma Antigen) in a blood test? (mrlabtest.com)
  • What does a normal blood CA 125 level mean? (mrlabtest.com)
  • For this study the upper limit of normal for CA 125 was 20 U/ml. (tau.ac.il)
  • The cutoff of 35 kU/L for CA 125 was determined from the distribution of values in healthy individuals to include 99% of the normal population. (medscape.com)
  • It's like a mole in that it's usually a normal, benign growth," explains Dr. Kho. (clevelandclinic.org)
  • What is a normal CA marker? (pfeiffertheface.com)
  • Which factors can raise the CA 125 (Carcinoma Antigen) in a blood test? (mrlabtest.com)
  • What can I do to lower the CA 125 (Carcinoma Antigen) in a blood test? (mrlabtest.com)
  • Where can I find more information about CA 125 (Carcinoma Antigen) in a blood test? (mrlabtest.com)
  • What does ca 72 4 mean in blood test? (pfeiffertheface.com)